SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-142283
Filing Date
2019-05-09
Accepted
2019-05-09 08:07:56
Documents
4
Period of Report
2019-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d741084d8k.htm 8-K 23227
2 EX-1.1 d741084dex11.htm EX-1.1 169529
3 EX-5.1 d741084dex51.htm EX-5.1 8966
4 GRAPHIC g741084g0509023040707.jpg GRAPHIC 2836
  Complete submission text file 0001193125-19-142283.txt   207001
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 19808865
SIC: 2834 Pharmaceutical Preparations